Aurobindo Purchases Portugal-Based Generis

Aurobindo

Aurobindo Pharma, one of the top five pharmaceutical companies in India, has announced the acquisition of Portugal-based Generis Farmaceutica for 135 million euros. The deal made Aurobindo the largest generic pharmaceutical company in the Portuguese market. The finalization of the deal is still contingent on approval from Portuguese regulatory authorities.  Aurobindo has been looking to expand its European footprint over the past ten years.

Read the source article at Money Control

About the Author

Related Posts

Leave a Reply

*